[Effect of Meisoindigo on Wnt signal pathway in K562 and HL-60 cells]

Ming-Xin Zuo1, Yan Li, Jian-Hua Zhou

  • 1Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.

Insights

Meisoindigo impacts the Wnt signaling pathway by inhibiting GSK-3beta and down-regulating beta-catenin and c-MYC. This mechanism is crucial for treating chronic myeloid leukemia.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The Wnt signaling pathway is implicated in various cancers, including chronic myeloid leukemia (CML).
  • Understanding the regulatory mechanisms of this pathway is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the effect of meisoindigo on the Wnt signaling pathway in K562 and HL-60 cells.
  • To elucidate the regulatory mechanism of meisoindigo in these leukemia cell lines.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect gene expression.
  • Western blot assay was employed to analyze protein expression levels.

Main Results:

  • Meisoindigo inhibited GSK-3beta phosphorylation and decreased beta-catenin and c-MYC gene expression in HL-60 cells.
  • In K562 cells, meisoindigo significantly decreased p-GSK-3beta and c-MYC protein expression but did not affect beta-catenin.
  • Meisoindigo decreased beta-catenin protein expression in HL-60 cells.

Conclusions:

  • Meisoindigo modulates the Wnt signaling pathway by inhibiting GSK-3beta and down-regulating beta-catenin and c-MYC.
  • These findings suggest meisoindigo's potential as a therapeutic agent for chronic myeloid leukemia.